VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer
AUSTIN, Texas, May 7, 2019 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that it has added to its extensive clinical trial program with the execution of a…